Evidence map›Paper›PMID 38267370›Full record

ArticleAngewandte Chemie (International ed. in English)2024

Green Light Promoted Iridium(III)/Copper(I)-Catalyzed Addition of Alkynes to Aziridinoquinoxalines Through the Intermediacy of Azomethine Ylides.

Oleksii Zhelavskyi, Seren Parikh, Yin-Jia Jhang, Richard J Staples, Paul M Zimmerman, Pavel Nagorny

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Oleksii ZhelavskyiChemistry Department, University of Michigan, Ann Arbor, MI 48109, USA.
Seren ParikhChemistry Department, University of Michigan, Ann Arbor, MI 48109, USA.
Yin-Jia JhangChemistry Department, University of Michigan, Ann Arbor, MI 48109, USA.
Richard J StaplesDepartment of Chemistry and Chemical Biology, Michigan State University, East Lansing, MI 48824, USA.ORCID https://orcid.org/0000-0003-2760-769X
Paul M ZimmermanChemistry Department, University of Michigan, Ann Arbor, MI 48109, USA.ORCID https://orcid.org/0000-0002-7444-1314
Pavel NagornyChemistry Department, University of Michigan, Ann Arbor, MI 48109, USA.ORCID https://orcid.org/0000-0002-7043-984X
University of Michigan · USMichigan State University · US

Funding

New Methods and Strategies for the Synthesis and Selective Derivatization of Natural ProductsR35GM136341 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Pavel Nagorny · 2020 to 2026
$2.6M
Mechanism-Guided Catalyst Development through Reaction Discovery Simulation - Equipment SupplementR35GM128830 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ZIMMERMAN, PAUL · 2018 to 2022
$1.9M
NIGMS NIH HHS R35 GM128830NIGMS NIH HHS R35 GM136341
6 · The paper itself

Abstract

This manuscript describes the development of alkyne addition to the aziridine moiety of aziridinoquinoxalines using dual Ir(III)/Cu(I) catalytic system under green light-emitting diode (LED) photolysis (λ

Indexed as

alkyne additionasymmetric catalysisaziridinesphotochemicalquinoxalines

Identifiers

PMID38267370
PMCPMC10939844
OpenAlexW4391187722

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.